Enlivex Therapeutics Ltd. logo

Enlivex Therapeutics Ltd.

ENLV | NASDAQ
Chart Builder DCF Calculator
$1.29
-$0.10 (-7.19%)
At close: Nov 5, 2026, 3:59 PM ET
$1.35
+$0.06 (+4.65%)
After-hours: Nov 5, 2026, 5:16 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
1.24B -15.01M -29.07M -31.06M -14.47M -11.82M
Depreciation & Amortization
332K 545K 835K 777K 546K 286K
Stock-Based Compensation
1.78M 2.07M 1.95M 2.71M 2.91M 670K
Other Working Capital
869K -1.64M -1.31M -364K -1.8M -342K
Other Non-Cash Items
-1.63B 614K 4.58M 2.81M 413K 167K
Deferred Income Tax
382.65M n/a n/a n/a -5.59M n/a
Change in Working Capital
815K -1.22M -1.82M 804K -1.36M -306K
Operating Cash Flow
-10.42M -13.01M -23.52M -23.95M -17.54M -11.01M
Capital Expenditures
-68K -103K -236K -8.12M -1.63M -1.02M
Cash Acquisitions
1.38M n/a n/a -9.71M -20.03M n/a
Purchase of Investments
-24.5M -32.37M -26.17M -1.61M -104.42M -19.96M
Sales Maturities Of Investments
41.37M 39.24M 301K 72.25M 67.63M n/a
Other Investing Acitivies
n/a 2.29M 133K 9.71M 20.03M -19.96K
Investing Cash Flow
-1.32M 9.06M -25.97M 62.52M -38.41M -20.98M
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 2K n/a n/a 7.81M 8.62M
Financial Cash Flow
10.38M 6.45M 360K 150K 60.98M 33.08M
Net Cash Flow
-1.41M 2.51M -49.13M 38.72M 4.62M 1.49M
Free Cash Flow
-10.48M -13.11M -23.76M -32.08M -19.17M -12.03M
Adj. Free Cash Flow
-12.27M -15.18M -25.71M -34.79M -22.08M -12.7M
Maintenance CapEx
-68K -103K -236K -8.12M -1.63M n/a
Growth CapEx
n/a n/a n/a n/a n/a -1.02M
Owner Earnings
-10.48M -13.11M -23.76M -32.08M -19.17M -11.01M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.